The current understanding of Stevens–Johnson syndrome and toxic epidermal necrolysis
- 1 November 2011
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 7 (6) , 803-815
Abstract
Stevens-Johnson syndrome has long been considered to resemble erythema multiforme with mucosal involvement, but is now thought to form a single disease entity with toxic epidermal necrolysis. Although Stevens-Johnson syndrome is less severe, etiology, genetic susceptibility and pathomechanism are the same for Stevens-Johnson syndrome/toxic epidermal necrolysis. The condition is mainly caused by drugs, but also by infections and probably other risk factors not yet identified. Identification of the cause is important for the individual patient and in cases of drug-induced disease withdrawal of the inducing drug(s) has an impact on the patient's prognosis. If an infectious cause is suspected, adequate anti-infective treatment is needed. Besides this, supportive management is crucial to improve the patient's state, probably more than specific immunomodulating treatments. Despite all of the therapeutic efforts, mortality is high and increases with disease severity, patients' age and underlying medical conditions. Survivors may suffer from long-term sequelae such as strictures of mucous membranes including severe eye problems.Keywords
This publication has 38 references indexed in Scilit:
- ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control AnalysisClinical Pharmacology & Therapeutics, 2010
- Risk factors for acute generalized exanthematous pustulosis (AGEP)—results of a multinational case–control study (EuroSCAR)British Journal of Dermatology, 2007
- Cutaneous Adverse Reactions to Valdecoxib Distinct From Stevens-Johnson Syndrome and Toxic Epidermal NecrolysisArchives of Dermatology, 2007
- Free Communications – Part IJournal of Investigative Dermatology, 2006
- Epidemiology of Staphylococcal Scalded Skin Syndrome in GermanyJournal of Investigative Dermatology, 2005
- Correlations Between Clinical Patterns and Causes of Erythema Multiforme Majus, Stevens-Johnson Syndrome, and Toxic Epidermal NecrolysisArchives of Dermatology, 2002
- Nevirapine and the risk of Stevens–Johnson syndrome or toxic epidermal necrolysisAIDS, 2001
- Nikolsky's sign: is it‘dry’ or is it ‘wet’?British Journal of Dermatology, 1997
- Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990–1992): Structure and results of a population-based registryJournal of Clinical Epidemiology, 1996
- Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens—Johnson syndrome and toxic epidermal necrolysisBritish Journal of Dermatology, 1996